A randomized controlled trial of Vulvar fractionated CO2-Laser therapy with and without concomitant topical clobetasol propionate 0.05% ointment for treatment of Vulvar lichen sclerosus (VULVIE)

Project: Research project

Project Details

Description

In this trial we will employ a gold-standard randomized double-blind placebo-controlled trial design to determine whether combining FxCO2-laser with the traditional therapy of clobetasol propionate 0.05% ointment (combined treatment) as compared to FxCO2-laser and placebo ointment (FxCO2-laser only) will improve treatment response in women undergoing FxCO2-laser for vulvar lichen sclerosus.
StatusActive
Effective start/end date7/1/216/30/24

Funding

  • MedStar Health Research Institute (Mueller AGMT 6/23/22)
  • Patty Brisben Foundation for Women's Sexual Health (Mueller AGMT 6/23/22)

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.